Condition: Venous Leg Ulcer (VLU) · Sponsor: MediWound Ltd
The main objective of this study is: To assess the efficacy and safety of EscharEx (EX-03 5% formulation) compared to placebo control,in debridement and wound bed preparation of Venous Leg Ulcers (VLU).
This description comes directly from the study's public registry record.
Yael Katz-levy, Ph.D. · +972-546774149 · yaelk@mediwound.com
Aya Ben-Yaakov, Ph.D · +972-508814005 · ayab@mediwound.com
Always discuss trial participation with your own doctor first.
| Limb Preservation Platform, Inc | Fresno, California, United States | Not Yet Recruiting |
| Angel City Research,Inc | Los Angeles, California, United States | Recruiting |
| Center for Clinical Research INC | San Francisco, California, United States | Recruiting |
| ILD Research Center | Vista, California, United States | Not Yet Recruiting |
| University of Miami | Miami, Florida, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| Boston Medical Center | Boston, Massachusetts, United States | Not Yet Recruiting |
| Rutgers New Jersey Medical Center | Newark, New Jersey, United States | Recruiting |
| Northwell Health Comprehensive Wound Healing Center | Lake Success, New York, United States | Active Not Recruiting |
| NYU Langone Health Long Island - Research & Academic Center | Mineola, New York, United States | Recruiting |
| Mount Sinai West | New York, New York, United States | Recruiting |
| Cutting Edge Research LLC., | Circleville, Ohio, United States | Recruiting |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06568627